
|
•
|
Revenues to be within the range of $290 million to $320 million; this range does not include significant one-time or pull forward of revenue.
|
|
•
|
Non-GAAP gross margin* expected to be
within the range of 20% to 24%
|
|
•
|
Non-GAAP operating expenses* to be
within the range of $88 million to $93 million.
|
|
Three Months Ended
December 31, |
Year Ended
December 31, |
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Unaudited
|
||||||||||||||||
|
Revenues
|
$
|
335,358
|
$
|
196,217
|
$
|
1,184,444
|
$
|
901,456
|
||||||||
|
Cost of revenues
|
260,887
|
308,471
|
988,163
|
1,778,660
|
||||||||||||
|
Gross profit (loss)
|
74,471
|
(112,254
|
)
|
196,281
|
(877,204
|
)
|
||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
51,726
|
62,238
|
221,255
|
277,237
|
||||||||||||
|
Sales and marketing
|
30,039
|
30,549
|
117,332
|
146,865
|
||||||||||||
|
General and administrative
|
24,489
|
36,370
|
101,035
|
147,455
|
||||||||||||
|
Other operating expenses, net
|
16,527
|
22,256
|
58,338
|
259,527
|
||||||||||||
|
Total operating expenses
|
122,781
|
151,413
|
497,960
|
831,084
|
||||||||||||
|
Operating loss
|
(48,310
|
)
|
(263,667
|
)
|
(301,679
|
)
|
(1,708,288
|
)
|
||||||||
|
Financial expense, net
|
(77,784
|
)
|
(12,199
|
)
|
(71,999
|
)
|
(14,570
|
)
|
||||||||
|
Other income (loss), net
|
(6,582
|
)
|
(76
|
)
|
(17,428
|
)
|
14,547
|
|||||||||
|
loss before income taxes
|
(132,676
|
)
|
(275,942
|
)
|
(391,106
|
)
|
(1,708,311
|
)
|
||||||||
|
Tax benefits (Income taxes)
|
564
|
(11,041
|
)
|
(13,382
|
)
|
(96,150
|
)
|
|||||||||
|
Net loss from equity method investments
|
(9
|
)
|
(456
|
)
|
(960
|
)
|
(1,896
|
)
|
||||||||
|
Net loss
|
$
|
(132,121
|
)
|
$
|
(287,439
|
)
|
$
|
(405,448
|
)
|
$
|
(1,806,357
|
)
|
||||
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
455,075
|
$
|
274,611
|
||||
|
Restricted cash
|
84,771
|
135,328
|
||||||
|
Marketable securities
|
38,097
|
311,279
|
||||||
|
Trade receivables, net of allowances of $17,224 and $43,038, respectively
|
267,441
|
160,423
|
||||||
|
Inventories, net
|
552,632
|
645,897
|
||||||
|
Prepaid expenses and other current assets
|
341,831
|
523,027
|
||||||
|
Total current assets
|
1,739,847
|
2,050,565
|
||||||
|
LONG-TERM ASSETS:
|
||||||||
|
Marketable securities
|
—
|
42,597
|
||||||
|
Property, plant and equipment, net
|
269,351
|
343,438
|
||||||
|
Operating lease right-of-use assets, net
|
48,178
|
41,393
|
||||||
|
Intangible assets, net
|
7,129
|
9,666
|
||||||
|
Goodwill
|
50,123
|
48,380
|
||||||
|
Loan receivables, net
|
—
|
45,678
|
||||||
|
Other long-term assets
|
67,566
|
64,736
|
||||||
|
Total long-term assets
|
442,347
|
595,888
|
||||||
|
Total assets
|
2,182,194
|
2,646,453
|
||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
271,983
|
107,543
|
||||||
|
Employees and payroll accruals
|
73,992
|
76,292
|
||||||
|
Warranty obligations
|
89,330
|
140,249
|
||||||
|
Deferred revenues and customers advances
|
70,371
|
140,870
|
||||||
|
Accrued expenses and other current liabilities
|
297,819
|
246,078
|
||||||
|
Convertible senior notes, net
|
—
|
346,305
|
||||||
|
Total current liabilities
|
803,495
|
1,057,337
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Convertible senior notes, net
|
331,561
|
330,006
|
||||||
|
Warranty obligations
|
268,559
|
292,116
|
||||||
|
Deferred revenues and customers advances
|
293,328
|
231,049
|
||||||
|
Finance lease liabilities
|
18,558
|
39,159
|
||||||
|
Operating lease liabilities
|
36,648
|
30,018
|
||||||
|
Other long-term liabilities
|
2,581
|
8,426
|
||||||
|
Total long-term liabilities
|
951,235
|
930,774
|
||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
|
Common stock of $0.0001 par value - Authorized: 125,000,000 shares; issued: 60,360,154 shares as of
December 31, 2025 and 58,780,490 shares as of December 31, 2024; outstanding: 60,360,154 shares as of December 31, 2025 and 58,027,126 shares as of December 31, 2024.
|
6
|
6
|
||||||
|
Additional paid-in capital
|
1,872,760
|
1,813,198
|
||||||
|
Treasury stock, at cost; 0 and 753,364 stocks held as of December 31, 2025 and December 31, 2024,
respectively
|
—
|
(50,194
|
)
|
|||||
|
Accumulated other comprehensive loss
|
(11,663
|
)
|
(76,477
|
)
|
||||
|
Accumulated deficit
|
(1,433,639
|
)
|
(1,028,191
|
)
|
||||
|
Total stockholders’ equity
|
427,464
|
658,342
|
||||||
|
Total liabilities and stockholders’
equity
|
$
|
2,182,194
|
$
|
2,646,453
|
||||
|
Year ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(405,448
|
)
|
$
|
(1,806,357
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation and amortization
|
30,511
|
59,865
|
||||||
|
Provision to write down inventories to net realizable value
|
17,827
|
738,757
|
||||||
|
Impairment of asset held-for-sale
|
42,746
|
—
|
||||||
|
Loss on impairment and disposal of property, plant and equipment
|
5,799
|
224,772
|
||||||
|
Stock-based compensation expenses
|
92,545
|
137,251
|
||||||
|
Loss from business disposition
|
17,875
|
—
|
||||||
|
Impairment of goodwill and intangible assets
|
—
|
24,674
|
||||||
|
Impairment of privately-held companies
|
21,587
|
5,000
|
||||||
|
Deferred income taxes, net
|
(761
|
)
|
79,209
|
|||||
|
Gain from repurchasing of convertible notes
|
—
|
(15,456
|
)
|
|||||
|
Loss from exchange rate fluctuations
|
2,594
|
11,918
|
||||||
|
Loss (gain) from sale of property, plant and equipment
|
(3,058
|
)
|
1,522
|
|||||
|
Cumulative translation adjustment, including intra-entity transactions that are of a long-term investment
reclassified from other comprehensive loss
|
58,916
|
—
|
||||||
|
Other items
|
866
|
1,508
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Trade receivables, net
|
(105,923
|
)
|
451,707
|
|||||
|
Inventories, net
|
97,230
|
67,799
|
||||||
|
Prepaid expenses and other assets
|
107,055
|
7,369
|
||||||
|
Operating lease right-of-use assets, net
|
11,342
|
15,805
|
||||||
|
Trade payables
|
164,808
|
(405,990
|
)
|
|||||
|
Warranty obligations
|
(72,101
|
)
|
(85,541
|
)
|
||||
|
Deferred revenues and customers advances
|
(5,781
|
)
|
119,519
|
|||||
|
Operating lease liabilities
|
(13,360
|
)
|
(15,829
|
)
|
||||
|
Accrued expenses and other liabilities
|
38,992
|
69,179
|
||||||
|
Net cash provided by (used in) operating activities
|
104,261
|
(313,319
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Investment in available-for-sale marketable securities
|
(471,158
|
)
|
(253,431
|
)
|
||||
|
Proceeds from maturities of available-for-sale marketable securities
|
713,413
|
719,454
|
||||||
|
Proceeds from sales of available-for-sale marketable securities
|
76,288
|
114,564
|
||||||
|
Purchase of property, plant and equipment
|
(23,467
|
)
|
(108,163
|
)
|
||||
|
Proceeds from sale of investment in privately-held company
|
4,000
|
—
|
||||||
|
Business dispositions, net of cash sold
|
(7,322
|
)
|
—
|
|||||
|
Business combinations, net of cash acquired
|
—
|
(10,417
|
)
|
|||||
|
Proceeds from sale of property, plant and equipment
|
37,642
|
1,876
|
||||||
|
Advance related to held-for-sale asset
|
7,000
|
—
|
||||||
|
Purchase of intangible assets
|
—
|
(10,000
|
)
|
|||||
|
Disbursements for loans receivables
|
—
|
(37,500
|
)
|
|||||
|
Investment in privately-held companies
|
(300
|
)
|
(25,664
|
)
|
||||
|
Proceeds from loans receivables
|
53,585
|
32,150
|
||||||
|
Repayment related to governmental grant
|
(6,643
|
)
|
—
|
|||||
|
Other investing activities
|
(3,156
|
)
|
(6,583
|
)
|
||||
|
Net cash provided by investing activities
|
379,882
|
416,286
|
||||||
|
Cash flows from financing activities:
|
||||||||
|
Repurchase of common stock
|
—
|
(50,194
|
)
|
|||||
|
Repurchase of convertible debt
|
(5,093
|
)
|
(267,900
|
)
|
||||
|
Proceeds from issuance of Notes 2029, net of issuance costs
|
—
|
329,214
|
||||||
|
Capped call transactions related to Notes 2029
|
—
|
(28,342
|
)
|
|||||
|
Repayment of convertible notes at maturity
|
(342,250
|
)
|
—
|
|||||
|
Tax withholding in connection with stock-based awards, net
|
2,665
|
(281
|
)
|
|||||
|
Other financing activities
|
(4,212
|
)
|
(2,626
|
)
|
||||
|
Net cash used in financing activities
|
(348,890
|
)
|
(20,129
|
)
|
||||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
3,344
|
(11,367
|
)
|
|||||
|
Increase in cash, cash equivalents and restricted cash including cash classified within current held-for-sale assets
|
138,597
|
71,471
|
||||||
|
Less: change in cash classified within current held-for-sale assets
|
(8,690
|
)
|
—
|
|||||
|
Increase in cash, cash equivalents, and restricted cash
|
129,907
|
71,471
|
||||||
|
Cash, cash equivalents and restricted cash, beginning of period
|
409,939
|
338,468
|
||||||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
539,846
|
$
|
409,939
|
||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December 31, 2025
|
September 30, 2025
|
June 30, 2025
|
March 31, 2025
|
December 31, 2024
|
December 31, 2025
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||||||||||||
|
Gross profit (loss) (GAAP)
|
$
|
74,471
|
$
|
72,143
|
$
|
32,131
|
$
|
17,536
|
$
|
(112,254
|
)
|
$
|
196,281
|
$
|
(877,204
|
)
|
$
|
703,823
|
||||||||||||||
|
Revenues from finance component
|
(456
|
)
|
(351
|
)
|
(304
|
)
|
(264
|
)
|
(254
|
)
|
(1,375
|
)
|
(984
|
)
|
(834
|
)
|
||||||||||||||||
|
Discontinued operation revenues
|
(1,107
|
)
|
(85
|
)
|
(8,132
|
)
|
(7,098
|
)
|
—
|
(16,422
|
)
|
—
|
—
|
|||||||||||||||||||
|
Discontinued operation cost of revenues
|
(331
|
)
|
(13,101
|
)
|
7,834
|
792
|
26,118
|
(4,806
|
)
|
24,921
|
36,648
|
|||||||||||||||||||||
|
Stock-based compensation
|
3,687
|
3,959
|
4,004
|
4,372
|
3,727
|
16,022
|
21,952
|
23,200
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
613
|
825
|
882
|
381
|
1,095
|
2,701
|
3,138
|
1,100
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired asset
|
495
|
501
|
483
|
491
|
484
|
1,970
|
5,412
|
6,038
|
||||||||||||||||||||||||
|
Restructuring charges
|
344
|
31
|
10
|
430
|
3,770
|
815
|
15,327
|
23,154
|
||||||||||||||||||||||||
|
Gross profit (loss) (Non-GAAP)
|
$
|
77,716
|
$
|
63,922
|
$
|
36,908
|
$
|
16,640
|
$
|
(77,314
|
)
|
$
|
195,186
|
$
|
(807,438
|
)
|
$
|
793,129
|
||||||||||||||
|
Gross margin (loss) (GAAP)
|
22.2
|
%
|
21.2
|
%
|
11.1
|
%
|
8.0
|
%
|
(57.2
|
)%
|
16.6
|
%
|
(97.3
|
)%
|
23.6
|
%
|
||||||||||||||||
|
Revenues from finance component
|
0.0
|
0.0
|
0.0
|
0.0
|
(0.1
|
)
|
(0.1
|
)
|
(0.1
|
)
|
0.0
|
|||||||||||||||||||||
|
Discontinued operation revenues
|
0.0
|
0.0
|
(2.8
|
)
|
(3.2
|
)
|
—
|
(1.4
|
)
|
—
|
—
|
|||||||||||||||||||||
|
Discontinued operation cost of revenues
|
0.0
|
(3.9
|
)
|
3.0
|
0.4
|
13.3
|
(0.4
|
)
|
2.8
|
1.2
|
||||||||||||||||||||||
|
Stock-based compensation
|
1.1
|
1.2
|
1.4
|
2.0
|
1.9
|
1.4
|
2.4
|
0.9
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
0.0
|
0.2
|
0.3
|
0.2
|
0.6
|
0.2
|
0.3
|
0.0
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired asset
|
0.0
|
0.1
|
0.2
|
0.2
|
0.2
|
0.3
|
0.6
|
0.2
|
||||||||||||||||||||||||
|
Restructuring charges
|
0.0
|
0.0
|
0.0
|
0.2
|
1.9
|
0.1
|
1.7
|
0.8
|
||||||||||||||||||||||||
|
Gross margin (loss) (Non-GAAP)
|
23.3
|
%
|
18.8
|
%
|
13.2
|
%
|
7.8
|
%
|
(39.4
|
)%
|
16.7
|
%
|
(89.6
|
)%
|
26.7
|
%
|
||||||||||||||||
|
Operating expenses (GAAP)
|
$
|
122,781
|
$
|
107,293
|
$
|
147,624
|
$
|
120,262
|
$
|
151,413
|
$
|
497,960
|
$
|
831,084
|
$
|
663,618
|
||||||||||||||||
|
Stock-based compensation - R&D
|
(8,442
|
)
|
(10,681
|
)
|
(9,856
|
)
|
(15,911
|
)
|
(10,653
|
)
|
(44,890
|
)
|
(62,546
|
)
|
(66,944
|
)
|
||||||||||||||||
|
Stock-based compensation - S&M
|
(4,298
|
)
|
(4,348
|
)
|
(4,342
|
)
|
(4,742
|
)
|
(4,452
|
)
|
(17,730
|
)
|
(27,328
|
)
|
(30,987
|
)
|
||||||||||||||||
|
Stock-based compensation - G&A
|
(3,546
|
)
|
(2,897
|
)
|
(1,059
|
)
|
(6,401
|
)
|
(5,600
|
)
|
(13,903
|
)
|
(25,425
|
)
|
(28,814
|
)
|
||||||||||||||||
|
Amortization and depreciation of acquired assets - R&D
|
—
|
—
|
—
|
—
|
(189
|
)
|
—
|
(1,000
|
)
|
(989
|
)
|
|||||||||||||||||||||
|
Amortization and depreciation of acquired assets - S&M
|
(116
|
)
|
(116
|
)
|
(116
|
)
|
(424
|
)
|
(442
|
)
|
(772
|
)
|
(1,599
|
)
|
(927
|
)
|
||||||||||||||||
|
Amortization and depreciation of acquired assets - G&A
|
—
|
—
|
—
|
—
|
—
|
—
|
(6
|
)
|
(15
|
)
|
||||||||||||||||||||||
|
Discontinued operation
|
(6,989
|
)
|
(316
|
)
|
(27,069
|
)
|
(1,522
|
)
|
(3,350
|
)
|
(35,896
|
)
|
(3,293
|
)
|
(388
|
)
|
||||||||||||||||
|
Restructuring charges
|
(423
|
)
|
(426
|
)
|
(867
|
)
|
(2,613
|
)
|
—
|
(4,329
|
)
|
(5,607
|
)
|
—
|
||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
(3,135
|
)
|
(672
|
)
|
(1,967
|
)
|
(224
|
)
|
(17,989
|
)
|
(5,998
|
)
|
(251,823
|
)
|
(30,790
|
)
|
||||||||||||||||
|
Gain (loss) from assets sales
|
(7,117
|
)
|
(158
|
)
|
(17,108
|
)
|
662
|
(1,910
|
)
|
(23,721
|
)
|
(5,746
|
)
|
1,262
|
||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
399
|
(1,786
|
)
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
(9
|
)
|
(135
|
)
|
||||||||||||||||||||||
|
Operating expenses (Non-GAAP)
|
$
|
88,715
|
$
|
87,679
|
$
|
85,240
|
$
|
89,087
|
$
|
106,828
|
$
|
350,721
|
$
|
447,101
|
$
|
503,105
|
||||||||||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025
|
March
31, 2025
|
December
31, 2024
|
December
31, 2025
|
December
31, 2024
|
December
31, 2023
|
|||||||||||||||||||||||||
|
Operating income (loss) (GAAP)
|
$
|
(48,310
|
)
|
$
|
(35,150
|
)
|
$
|
(115,493
|
)
|
$
|
(102,726
|
)
|
$
|
(263,667
|
)
|
$
|
(301,679
|
)
|
$
|
(1,708,288
|
)
|
$
|
40,205
|
|||||||||
|
Revenues from finance component
|
(456
|
)
|
(351
|
)
|
(304
|
)
|
(264
|
)
|
(254
|
)
|
(1,375
|
)
|
(984
|
)
|
(834
|
)
|
||||||||||||||||
|
Discontinued operation
|
5,551
|
(12,870
|
)
|
26,771
|
(4,784
|
)
|
29,468
|
14,668
|
28,214
|
37,036
|
||||||||||||||||||||||
|
Stock-based compensation
|
19,973
|
21,885
|
19,261
|
31,426
|
24,432
|
92,545
|
137,251
|
149,945
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
613
|
825
|
882
|
381
|
1,095
|
2,701
|
3,138
|
1,100
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
611
|
617
|
599
|
915
|
1,115
|
2,742
|
8,017
|
7,969
|
||||||||||||||||||||||||
|
Restructuring charges
|
767
|
457
|
877
|
3,043
|
3,770
|
5,144
|
20,934
|
23,154
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
3,135
|
672
|
1,967
|
224
|
17,989
|
5,998
|
251,823
|
30,790
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
7,117
|
158
|
17,108
|
(662
|
)
|
1,910
|
23,721
|
5,746
|
(1,262
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(399
|
)
|
1,786
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
9
|
135
|
||||||||||||||||||||||||
|
Operating income (loss) (Non-GAAP)
|
$
|
(10,999
|
)
|
$
|
(23,757
|
)
|
$
|
(48,332
|
)
|
$
|
(72,447
|
)
|
$
|
(184,142
|
)
|
$
|
(155,535
|
)
|
$
|
(1,254,539
|
)
|
$
|
290,024
|
|||||||||
|
Financial income (expense), net (GAAP)
|
$
|
(77,784
|
)
|
$
|
3,040
|
$
|
(7,323
|
)
|
$
|
10,068
|
$
|
(12,199
|
)
|
$
|
(71,999
|
)
|
$
|
(14,570
|
)
|
$
|
41,212
|
|||||||||||
|
Non cash interest expense
|
4,420
|
4,462
|
4,326
|
4,051
|
3,920
|
17,259
|
14,877
|
12,703
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
3,360
|
1,552
|
7,151
|
(1,633
|
)
|
1,089
|
10,430
|
(744
|
)
|
(3,055
|
)
|
|||||||||||||||||||||
|
Discontinued operation
|
1,402
|
(958
|
)
|
2,265
|
(276
|
)
|
—
|
2,433
|
—
|
—
|
||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
59,520
|
—
|
—
|
—
|
—
|
59,520
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement agreement
|
10,963
|
—
|
—
|
—
|
—
|
10,963
|
—
|
—
|
||||||||||||||||||||||||
|
Financial income (expense), net (Non-GAAP)
|
$
|
1,881
|
$
|
8,096
|
$
|
6,419
|
$
|
12,210
|
$
|
(7,190
|
)
|
$
|
28,606
|
$
|
(437
|
)
|
$
|
50,860
|
||||||||||||||
|
Other income (loss) (GAAP)
|
$
|
(6,582
|
)
|
$
|
(15,011
|
)
|
$
|
4,017
|
$
|
148
|
$
|
(76
|
)
|
$
|
(17,428
|
)
|
$
|
14,547
|
$
|
(318
|
)
|
|||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
(2
|
)
|
76
|
(2
|
)
|
(2,966
|
)
|
193
|
|||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(1,125
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
(146
|
)
|
—
|
(146
|
)
|
(15,456
|
)
|
—
|
|||||||||||||||||||||
|
Gain From sale of private held companies
|
155
|
—
|
(4,017
|
)
|
—
|
—
|
(3,862
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
6,427
|
15,011
|
—
|
—
|
—
|
21,438
|
5,000
|
—
|
||||||||||||||||||||||||
|
Other income (loss) (Non-GAAP)
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
(125
|
)
|
|||||||||||||||
|
Income tax benefit (expense) (GAAP)
|
$
|
564
|
$
|
(2,563
|
)
|
$
|
(5,657
|
)
|
$
|
(5,726
|
)
|
$
|
(11,041
|
)
|
$
|
(13,382
|
)
|
$
|
(96,150
|
)
|
$
|
(46,420
|
)
|
|||||||||
|
Income tax adjustment
|
389
|
(124
|
)
|
(100
|
)
|
(155
|
)
|
(176
|
)
|
10
|
39,007
|
(45,896
|
)
|
|||||||||||||||||||
|
Income tax benefit (expense) (Non-GAAP)
|
$
|
953
|
$
|
(2,687
|
)
|
$
|
(5,757
|
)
|
$
|
(5,881
|
)
|
$
|
(11,217
|
)
|
$
|
(13,372
|
)
|
$
|
(57,143
|
)
|
$
|
(92,316
|
)
|
|||||||||
|
Equity method investments income (loss) (GAAP)
|
$
|
(9
|
)
|
$
|
(376
|
)
|
$
|
(288
|
)
|
$
|
(287
|
)
|
$
|
(456
|
)
|
$
|
(960
|
)
|
$
|
(1,896
|
)
|
$
|
(350
|
)
|
||||||||
|
Loss from equity method investments
|
9
|
376
|
288
|
287
|
456
|
960
|
1,896
|
350
|
||||||||||||||||||||||||
|
Equity method investments income (loss) (Non-GAAP)
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||||||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025
|
March
31, 2025 |
December
31, 2024
|
December
31, 2025
|
December
31, 2024
|
December
31, 2023 |
|||||||||||||||||||||||||
|
Net income (loss) (GAAP)
|
$
|
(132,121
|
)
|
$
|
(50,060
|
)
|
$
|
(124,744
|
)
|
$
|
(98,523
|
)
|
$
|
(287,439
|
)
|
$
|
(405,448
|
)
|
$
|
(1,806,357
|
)
|
$
|
34,329
|
|||||||||
|
Revenues from finance component
|
(456
|
)
|
(351
|
)
|
(304
|
)
|
(264
|
)
|
(254
|
)
|
(1,375
|
)
|
(984
|
)
|
(834
|
)
|
||||||||||||||||
|
Discontinued operation
|
6,953
|
(13,828
|
)
|
29,036
|
(5,060
|
)
|
29,468
|
17,101
|
28,214
|
37,036
|
||||||||||||||||||||||
|
Stock-based compensation
|
19,973
|
21,885
|
19,261
|
31,426
|
24,432
|
92,545
|
137,251
|
149,945
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
613
|
825
|
882
|
381
|
1,095
|
2,701
|
3,138
|
1,100
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
611
|
617
|
599
|
915
|
1,115
|
2,742
|
8,017
|
7,969
|
||||||||||||||||||||||||
|
Restructuring charges
|
767
|
457
|
877
|
3,043
|
3,770
|
5,144
|
20,934
|
23,154
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
3,135
|
672
|
1,967
|
224
|
17,989
|
5,998
|
251,823
|
30,790
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
7,117
|
158
|
17,108
|
(662
|
)
|
1,910
|
23,721
|
5,746
|
(1,262
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(399
|
)
|
1,786
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
9
|
135
|
||||||||||||||||||||||||
|
Non cash interest expense
|
4,420
|
4,462
|
4,326
|
4,051
|
3,920
|
17,259
|
14,877
|
12,703
|
||||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
59,520
|
—
|
—
|
—
|
—
|
59,520
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement agreement
|
10,963
|
—
|
—
|
—
|
—
|
10,963
|
—
|
—
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
3,360
|
1,552
|
7,151
|
(1,633
|
)
|
1,089
|
10,430
|
(744
|
)
|
(3,055
|
)
|
|||||||||||||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
(2
|
)
|
76
|
(2
|
)
|
(2,966
|
)
|
193
|
|||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(1,125
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
(146
|
)
|
—
|
(146
|
)
|
(15,456
|
)
|
—
|
|||||||||||||||||||||
|
Gain From sale of private held companies
|
155
|
—
|
(4,017
|
)
|
—
|
—
|
(3,862
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
6,427
|
15,011
|
—
|
—
|
—
|
21,438
|
5,000
|
—
|
||||||||||||||||||||||||
|
Income tax adjustment
|
389
|
(124
|
)
|
(100
|
)
|
(155
|
)
|
(176
|
)
|
10
|
39,007
|
(45,896
|
)
|
|||||||||||||||||||
|
equity method adjustments
|
9
|
376
|
288
|
287
|
456
|
960
|
1,896
|
350
|
||||||||||||||||||||||||
|
Net income (loss) (Non-GAAP)
|
$
|
(8,165
|
)
|
$
|
(18,348
|
)
|
$
|
(47,670
|
)
|
$
|
(66,118
|
)
|
$
|
(202,549
|
)
|
$
|
(140,301
|
)
|
$
|
(1,312,119
|
)
|
$
|
248,443
|
|||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025 |
March
31, 2025
|
December
31, 2024
|
December
31, 2025
|
December
31, 2024
|
December
31, 2023
|
|||||||||||||||||||||||||
|
Net basic earnings (loss) per share (GAAP)
|
$
|
(2.21
|
)
|
$
|
(0.84
|
)
|
$
|
(2.13
|
)
|
$
|
(1.70
|
)
|
$
|
(5.00
|
)
|
$
|
(6.88
|
)
|
$
|
(31.64
|
)
|
$
|
0.61
|
|||||||||
|
Revenues from finance component
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
0.00
|
(0.01
|
)
|
(0.02
|
)
|
(0.02
|
)
|
(0.02
|
)
|
|||||||||||||||||
|
Discontinued operation
|
0.12
|
(0.23
|
)
|
0.50
|
(0.09
|
)
|
0.52
|
0.29
|
0.49
|
0.66
|
||||||||||||||||||||||
|
Stock-based compensation
|
0.33
|
0.37
|
0.33
|
0.54
|
0.42
|
1.57
|
2.41
|
2.65
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
0.01
|
0.01
|
0.01
|
0.01
|
0.02
|
0.05
|
0.05
|
0.02
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
0.01
|
0.01
|
0.01
|
0.02
|
0.02
|
0.04
|
0.14
|
0.14
|
||||||||||||||||||||||||
|
Restructuring charges
|
0.02
|
0.01
|
0.02
|
0.05
|
0.07
|
0.09
|
0.37
|
0.41
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
0.05
|
0.01
|
0.03
|
0.00
|
0.31
|
0.10
|
4.41
|
0.54
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
0.12
|
0.00
|
0.30
|
(0.01
|
)
|
0.03
|
0.40
|
0.10
|
(0.02
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.01
|
)
|
0.03
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
0.00
|
0.00
|
||||||||||||||||||||||||
|
Non cash interest expense
|
0.07
|
0.08
|
0.07
|
0.07
|
0.07
|
0.30
|
0.26
|
0.23
|
||||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
1.00
|
—
|
—
|
—
|
—
|
1.01
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement
|
0.18
|
—
|
—
|
—
|
—
|
0.18
|
—
|
—
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
0.06
|
0.02
|
0.12
|
(0.03
|
)
|
0.02
|
0.18
|
(0.01
|
)
|
(0.06
|
)
|
|||||||||||||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
0.00
|
0.00
|
0.00
|
(0.05
|
)
|
0.01
|
|||||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.02
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
0.00
|
—
|
0.00
|
(0.27
|
)
|
—
|
|||||||||||||||||||||||
|
Gain From sale of private held companies
|
0.00
|
—
|
(0.06
|
)
|
—
|
—
|
(0.07
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
0.11
|
0.26
|
—
|
—
|
—
|
0.36
|
0.09
|
—
|
||||||||||||||||||||||||
|
Income tax adjustment
|
0.00
|
(0.01
|
)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.68
|
(0.81
|
)
|
||||||||||||||||||||||
|
equity method adjustments
|
0.00
|
0.01
|
0.00
|
0.00
|
0.01
|
0.02
|
0.03
|
0.00
|
||||||||||||||||||||||||
|
Net basic earnings (loss) per share (Non-GAAP)
|
$
|
(0.14
|
)
|
$
|
(0.31
|
)
|
$
|
(0.81
|
)
|
$
|
(1.14
|
)
|
$
|
(3.52
|
)
|
$
|
(2.38
|
)
|
$
|
(22.99
|
)
|
$
|
4.39
|
|||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025
|
March
31, 2025
|
December
31, 2024
|
December
31, 2025
|
December
31, 2024 |
December
31, 2023
|
|||||||||||||||||||||||||
|
Net diluted earnings (loss) per share (GAAP)
|
$
|
(2.21
|
)
|
$
|
(0.84
|
)
|
$
|
(2.13
|
)
|
$
|
(1.70
|
)
|
$
|
(5.00
|
)
|
$
|
(6.88
|
)
|
$
|
(31.64
|
)
|
$
|
0.60
|
|||||||||
|
Revenues from finance component
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
0.00
|
(0.01
|
)
|
(0.02
|
)
|
(0.02
|
)
|
(0.01
|
)
|
|||||||||||||||||
|
Discontinued operation
|
0.12
|
(0.23
|
)
|
0.50
|
(0.09
|
)
|
0.52
|
0.29
|
0.49
|
0.64
|
||||||||||||||||||||||
|
Stock-based compensation
|
0.33
|
0.37
|
0.33
|
0.54
|
0.42
|
1.57
|
2.41
|
2.57
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
0.01
|
0.01
|
0.01
|
0.01
|
0.02
|
0.05
|
0.05
|
0.02
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
0.01
|
0.01
|
0.01
|
0.02
|
0.02
|
0.04
|
0.14
|
0.14
|
||||||||||||||||||||||||
|
Restructuring charges
|
0.02
|
0.01
|
0.02
|
0.05
|
0.07
|
0.09
|
0.37
|
0.40
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
0.05
|
0.01
|
0.03
|
0.00
|
0.31
|
0.10
|
4.41
|
0.53
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
0.12
|
0.00
|
0.30
|
(0.01
|
)
|
0.03
|
0.40
|
0.10
|
(0.02
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.01
|
)
|
0.03
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
0.00
|
0.00
|
||||||||||||||||||||||||
|
Non cash interest expense
|
0.07
|
0.08
|
0.07
|
0.07
|
0.07
|
0.30
|
0.26
|
0.03
|
||||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
1.00
|
—
|
—
|
—
|
—
|
1.01
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement agreement
|
0.18
|
—
|
—
|
—
|
—
|
0.18
|
—
|
—
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
0.06
|
0.02
|
0.12
|
(0.03
|
)
|
0.02
|
0.18
|
(0.01
|
)
|
(0.05
|
)
|
|||||||||||||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
0.00
|
0.00
|
0.00
|
(0.05
|
)
|
0.00
|
|||||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.02
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
0.00
|
—
|
0.00
|
(0.27
|
)
|
—
|
|||||||||||||||||||||||
|
Gain From sale of private held companies
|
0.00
|
—
|
(0.06
|
)
|
—
|
—
|
(0.07
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
0.11
|
0.26
|
0.00
|
—
|
—
|
0.36
|
0.09
|
—
|
||||||||||||||||||||||||
|
Income tax adjustment
|
0.00
|
(0.01
|
)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.68
|
(0.76
|
)
|
||||||||||||||||||||||
|
equity method adjustments
|
0.00
|
0.01
|
0.00
|
0.00
|
0.01
|
0.02
|
0.03
|
0.00
|
||||||||||||||||||||||||
|
Net diluted earnings (loss) per share (Non-GAAP)
|
$
|
(0.14
|
)
|
$
|
(0.31
|
)
|
$
|
(0.81
|
)
|
$
|
(1.14
|
)
|
$
|
(3.52
|
)
|
$
|
(2.38
|
)
|
$
|
(22.99
|
)
|
$
|
4.12
|
|||||||||
|
Number of shares used in computing net diluted earnings (loss) per share (GAAP)
|
59,828,042
|
59,278,269
|
58,567,394
|
58,121,502
|
57,467,946
|
58,954,380
|
57,082,182
|
57,237,518
|
||||||||||||||||||||||||
|
Stock-based compensation
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
725,859
|
||||||||||||||||||||||||
|
Notes due 2025
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
2,276,818
|
||||||||||||||||||||||||
|
Number of shares used in computing net diluted earnings (loss) per share (Non-GAAP)
|
59,828,042
|
59,278,269
|
58,567,394
|
58,121,502
|
57,467,946
|
58,954,380
|
57,082,182
|
60,240,195
|
||||||||||||||||||||||||
|
Net cash provided by (used in) operating activities (GAAP)
|
$ |
52,629
|
$ |
25,608
|
$ |
(7,799
|
)
|
$ |
33,823
|
$ |
37,804
|
$ |
104,261
|
$ |
(313,319
|
)
|
$ |
(180,113
|
)
|
|||||||||||||
|
Purchases of property and equipment
|
(9,293
|
)
|
(2,809
|
)
|
(1,256
|
)
|
(10,109
|
)
|
(12,258
|
)
|
(23,467
|
)
|
(108,163
|
)
|
(170,523
|
)
|
||||||||||||||||
|
Discontinued operation
|
—
|
—
|
—
|
(3,867
|
)
|
—
|
(3,867
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Free cash flow (deficit) (Non-GAAP)
|
$ |
43,336
|
$ |
22,799
|
$ |
(9,055
|
)
|
$ |
19,847
|
$ |
25,546
|
$ |
76,927
|
$ |
(421,482
|
)
|
$ |
(350,636
|
)
|
|||||||||||||